• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09203095190
Device Problems False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/11/2021
Event Type  malfunction  
Manufacturer Narrative
Other text : na.
 
Event Description
The initial reporter stated they were having issues with third party control recovery for the elecsys anti-sars-cov-2 assay on a cobas 6000 e 601 module.The issue started when new anti-sars-cov-2 reagent lot 56426000 was placed on board the analyzer on 09-aug-2021.Roche manufactured controls were provided to the customer and these recovered within range on 11-aug-2021.In order to troubleshoot the third party control issue, the customer pulled some patient samples that had been originally tested on (b)(6) 2021 and repeated these after the roche controls were tested on 11-aug-2021.The initial sample values from (b)(6) 2021 were believed to be correct.Of the repeated samples, three samples that were initially non-reactive, now recover with reactive values.No incorrect results were reported outside of the laboratory.The first sample initially resulted in an anti-sars-cov-2 value of 0.312 coi (non-reactive) on (b)(6) 2021.The sample was repeated on (b)(6) 2021, resulting in a value of 1.30 coi (reactive).The second sample initially resulted in an anti-sars-cov-2 value of 0.741 coi (non-reactive) on (b)(6) 2021.The sample was repeated on (b)(6) 2021, resulting in a value of 5.00 coi (reactive).The third sample initially resulted in an anti-sars-cov-2 value of 0.293 coi (non-reactive) on (b)(6) 2021.The sample was repeated on (b)(6) 2021, resulting in a value of 1.52 coi (reactive).The serial number of the e 601 analyzer is (b)(4).
 
Manufacturer Narrative
The customer's calibration results were ok.The customer's qc was recovering high.The negative qc material resulted in a reactive result.The investigation reviewed the system alarm trace and no abnormalities were found.The field service engineer performed system maintenance and replaced various parts.He performed performance testing and roche qc with acceptable results.The customer's third-party controls did not pass.After service, the customer did not respond to any follow-ups.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12367845
MDR Text Key269524781
Report Number1823260-2021-02471
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EUA200514
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 10/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number09203095190
Device Lot Number56426000
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-